These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1905533

  • 1. Hippocampal modulation of nucleus accumbens: behavioral evidence from amphetamine-induced activity profiles.
    Whishaw IQ, Mittleman G.
    Behav Neural Biol; 1991 May; 55(3):289-306. PubMed ID: 1905533
    [Abstract] [Full Text] [Related]

  • 2. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
    Whishaw IQ, Fiorino D, Mittleman G, Castañeda E.
    Brain Res; 1992 Mar 27; 576(1):1-11. PubMed ID: 1381257
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P, Robbins TW.
    Neuropharmacology; 1985 Jan 27; 24(1):25-31. PubMed ID: 3920545
    [Abstract] [Full Text] [Related]

  • 4. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R, Winn P.
    Behav Brain Res; 1992 Nov 15; 51(2):127-37. PubMed ID: 1466779
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of amphetamine-stereotypy by mesostriatal dopamine depletion enhances plasma corticosterone: implications for stereotypy as a coping response.
    Jones GH, Mittleman G, Robbins TW.
    Behav Neural Biol; 1989 Jan 15; 51(1):80-91. PubMed ID: 2705984
    [Abstract] [Full Text] [Related]

  • 6. Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists.
    Lee N, Radke JM, Vincent SR.
    Behav Brain Res; 1988 Jul 15; 29(1-2):179-83. PubMed ID: 2900014
    [Abstract] [Full Text] [Related]

  • 7. Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei.
    Makanjuola RO, Ashcroft GW.
    Psychopharmacology (Berl); 1982 Jul 15; 76(4):33-40. PubMed ID: 6812107
    [Abstract] [Full Text] [Related]

  • 8. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G, LeDuc PA, Whishaw IQ.
    Behav Brain Res; 1993 Jun 30; 55(2):253-67. PubMed ID: 8102851
    [Abstract] [Full Text] [Related]

  • 9. Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task.
    Robbins TW, Giardini V, Jones GH, Reading P, Sahakian BJ.
    Behav Brain Res; 1990 May 28; 38(3):243-61. PubMed ID: 2114120
    [Abstract] [Full Text] [Related]

  • 10. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR, Robbins TW.
    Psychopharmacology (Berl); 1986 May 28; 90(3):390-7. PubMed ID: 3097729
    [Abstract] [Full Text] [Related]

  • 11. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1977 Mar 04; 123(1):89-111. PubMed ID: 300267
    [Abstract] [Full Text] [Related]

  • 12. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia.
    Bardgett ME, Jackson JL, Taylor GT, Csernansky JG.
    Behav Brain Res; 1995 Oct 04; 70(2):153-64. PubMed ID: 8561906
    [Abstract] [Full Text] [Related]

  • 13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 04; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 14. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH, Swerdlow NR, Koob GF.
    Behav Neurosci; 1988 Aug 04; 102(4):544-52. PubMed ID: 3139012
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus.
    Wilkinson LS, Mittleman G, Torres E, Humby T, Hall FS, Robbins TW.
    Behav Brain Res; 1993 Jun 30; 55(2):143-50. PubMed ID: 8395178
    [Abstract] [Full Text] [Related]

  • 16. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.
    Brundin P, Strecker RE, Londos E, Björklund A.
    Exp Brain Res; 1987 Jun 30; 69(1):183-94. PubMed ID: 3125059
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C, Fibiger HC, Phillips AG.
    Brain Res; 1982 Dec 16; 253(1-2):185-93. PubMed ID: 6817850
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
    Kuczenski R, Segal DS, Aizenstein ML.
    J Neurosci; 1991 Sep 16; 11(9):2703-12. PubMed ID: 1715389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.